MIDAS SPCT: Maintaining Implementation Through Dynamic Adaptations (MIDAS) Suicide Prevention 2.0 Clinical Telehealth

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Active, not recruiting
CT.gov ID
NCT06011759
Collaborator
(none)
4
1
2
35
0.1

Study Details

Study Description

Brief Summary

Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program helps providers improve the way they treat VA patients. This project will focus on increasing referrals to the Suicide Prevention 2.0 Clinical Telehealth (SP 2.0) initiative through the delivery of Academic Detailing and LEAP (a team-based quality improvement program). SP 2.0 provides accessible, evidence-based suicide prevention treatment to all Veterans with a history of suicidal self-directed violence or preparatory behaviors in the past 12 months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Academic Detailing (AD)
  • Behavioral: LEAP
  • Behavioral: Usual care
N/A

Detailed Description

Sustained integration of evidence-based practices (EBPs) is a challenge within many healthcare systems, especially in settings that have already strived but failed to achieve longer-term goals. The Veterans Affairs (VA) Maintaining Implementation through Dynamic Adaptations (MIDAS) Quality Enhancement Research Initiative (QUERI) program was funded as a series of trials to test multi-component implementation strategies to sustain optimal use of EBPs. The current project focuses on increasing referrals to the Suicide Prevention 2.0 Clinical Telehealth (SP 2.0) initiative.

The investigators have recruited 4 sites for this non-randomized intervention project. Sites have agreed to participate in pre-implementation interviews to gather information regarding barriers and facilitators to use of the SP 2.0 initiative. Sites will then be provided with tailored feedback regarding interview findings and potential use of Academic Detailing and LEAP to address these. Sites may then select to receive either Academic Detailing and/or LEAP which will be provided by MIDAS QUERI. Sites will be compared to control sites which will be matched based on similar baseline referral rates. Primary outcome will be rate of SP 2.0 referral adjusted for pre-intervention rate.

Study Design

Study Type:
Interventional
Actual Enrollment :
4 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
A multi-faceted implementation intervention including qualitative interviews and feedback and optional delivery of Academic Detailing and/or LEAP.A multi-faceted implementation intervention including qualitative interviews and feedback and optional delivery of Academic Detailing and/or LEAP.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Maintaining Implementation Through Dynamic Adaptations (MIDAS) - Suicide Prevention 2.0 Clinical Telehealth (SP 2.0) (QUE 20-025)
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Oct 31, 2024
Anticipated Study Completion Date :
Sep 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

A multi-faceted implementation intervention including qualitative interviews and feedback and optional delivery of Academic Detailing and/or LEAP.

Behavioral: Academic Detailing (AD)
The National Resource Center for Academic Detailing (NaRCAD) describes AD as "an innovative, one-on-one outreach education technique that helps clinicians provide evidence-based care to their patients. Using an accurate, up-to-date synthesis of the best clinical evidence in an engaging format, academic detailers ignite clinician behavior change, ultimately improving patient health. A successful AD visit is highly interactive, always a dialogue, and assesses a clinician's individual needs, beliefs, attitudes, issues, and concerns in order to promote better [practice]."

Behavioral: LEAP
Learn. Engage. Act. Process (LEAP) program is a structured 6-month core curriculum plus 6 monthly collaborative sessions. The LEAP quality improvement program engages frontline teams in sustained incremental improvements of EBPs over a six-month period, allowing space for busy clinicians to learn and immediately apply fundamental QI skills. LEAP encompasses: 1) a structured, accessible curriculum based on the Institute for Healthcare Improvement's (IHI) Model for Improvement and Plan-Do-Study-Act cycles of change; 2) team-based, hands-on learning, and 3) coaching support and a QI network to enhance learning and accountability.

Experimental: Control

Control sites will be selected to match intervention sites on baseline referral rates.

Behavioral: Usual care
Experimental control sites receiving usual care

Outcome Measures

Primary Outcome Measures

  1. Referral to SP 2.0 Clinic [Baseline to 12-months post-baseline]

    Change in percentage of referrals to the Suicide Prevention 2.0 Clinical Telehealth (SP 2.0) initiative.

Secondary Outcome Measures

  1. Receipt of Cognitive Behavioral Therapy for Suicide Prevention at SP 2.0 clinic [Baseline to 12-months post-baseline]

    The change in prevalence of any receipt of Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP). Receipt of any CBT-SP will be measured by extracting from the medical record note templates completed by CBT-SP therapists.

  2. Completion of Cognitive Behavioral Therapy for Suicide Prevention at SP 2.0 clinic [Baseline to 12-months post-baseline]

    The change in prevalence of completion of Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP). Completion of any CBT-SP will be measured by extracting from the medical record note templates completed by CBT-SP therapists.

  3. Receipt of Problem Solving Therapy for Suicide Prevention [Baseline to 12-months post-baseline]

    The change in prevalence of any receipt of Problem Solving Therapy for Suicide Prevention (PST-SP). Receipt of any PST-SP will be measured by extracting from the medical record note templates completed by PST-SP therapists.

  4. Completion of Problem Solving Therapy for Suicide Prevention [Baseline to 12-months post-baseline]

    The change in prevalence of completion of Problem Solving Therapy for Suicide Prevention (PST-SP). Completion of any PST-SP will be measured by extracting from the medical record note templates completed by PST-SP therapists.

  5. Receipt of Dialectical Behavior Therapy [Baseline to 12-months post-baseline]

    The change in prevalence of any receipt of Dialectical Behavior Therapy for Suicide Prevention (DBT-SP). Receipt of any DBT-SP will be measured by extracting from the medical record note templates completed by DBT-SP therapists.

  6. Completion of Dialectical Behavior Therapy [Baseline to 12-months post-baseline]

    The change in prevalence of completion of Dialectical Behavior Therapy for Suicide Prevention (DBT-SP). Completion of any DBT-SP will be measured by extracting from the medical record note templates completed by DBT-SP therapists.

Other Outcome Measures

  1. Change in Employee Engagement in Quality Improvement [Baseline to 12-months post-baseline]

    3-item pilot measure of the extent to which employees engage in quality improvement activities. Scores are 1-5 with higher ratings indicating more engagement in QI.

  2. Change in Employee Burnout [Baseline to 12-months post-baseline]

    3-item measure comprising I feel burned out from my work (Exhaustion), I worry that this job is hardening me emotionally (Depersonalization), and I have accomplished many worthwhile things in this job (Reduced Achievement; reverse score). "High Burnout" measures the percent of staff who are feeling burned out on all three burnout symptoms at a frequency of "once a week" to "every day." Scored: 0-100%, where LOWER score is more favorable. Exhaustion (physical burnout) Depersonalization (emotional burnout), Reduced Achievement (cognitive burnout).

  3. Change in Workgroup Cohesion & Engagement [Baseline to 12-months post-baseline]

    7-item measure from the VA's newly developed Patient Safety Culture. Values 1 to 5 where higher values indicate more positive scores.

  4. Change in quality improvement skills application [Baseline to 12-months post-baseline]

    16-item measure of change in quality improvement skills application. Values 1 to 4 where higher values indicate more frequent use of quality improvement skills.

  5. Change in provider satisfaction with academic detailing [Baseline to 12-months post-baseline]

    7-item measure of satisfaction with Academic Detailing. Values 1 to 5 where higher values indicate higher satisfaction.

  6. Change in provider satisfaction with LEAP [Baseline to 12-months post-baseline]

    6-item measure of satisfaction with LEAP. Values 1 to 5 where higher values indicate higher satisfaction.

  7. Change in Best Places to Work Score [Baseline to 12-months post-baseline]

    3-item scale. "Best Places to Work" is a summary measure of the group's satisfaction with the job, organization, and likelihood to recommend VA as a good place to work. This is a measure normally administered within the All-employee Survey (AES). This score is functionally similar to those reported for Federal agencies by the Partnership for Public Service (http://bestplacestowork.org). Overall Satisfaction (% Positive), Organization Satisfaction (% Positive), and Recommend My Organization (% Positive). Score as Percent positive = "Very Satisfied/Satisfied" or "Strongly Agree/Agree."

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Note- the investigators are recruiting clinics/medical centers - not individual patients. Prior to implementation, the investigators will work with sites to ensure they have met the preconditions necessary to begin sustained optimization of the EBP:

    1. a team leader or champion
    1. an identified department with service leadership buy-in and control over the processes/practices impacted by the implementation
    1. readily accessible data to measure process and impact of the implementation and use of the EBP
    1. availability of required resources
Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor Michigan United States 48105-2303

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Paul N Pfeiffer, MD MS, VA Ann Arbor Healthcare System, Ann Arbor, MI
  • Principal Investigator: Jacob E Kurlander, MD MS MS, VA Ann Arbor Healthcare System, Ann Arbor, MI
  • Principal Investigator: Jeremy B. Sussman, MD MS, VA Ann Arbor Healthcare System, Ann Arbor, MI

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT06011759
Other Study ID Numbers:
  • QUX 23-001
First Posted:
Aug 25, 2023
Last Update Posted:
Aug 25, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2023